comparemela.com
Home
Live Updates
Ocugen - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Ocugen - Page 1 : comparemela.com
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc
NEW YORK, May 04, 2024 (GLOBE NEWSWIRE) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc..
New york
United states
Phillip kim
Laurence rosen
Rosen law firm
Ocugen inc
Chinese company
Securities class action services
Class period
Law firm
Class action services
Class has been
The rosen law firm pa
Rosen law firm
Nasdaq ocgn
Lass action
ROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc..
New york
United states
Phillip kim
Laurence rosen
Chinese company
Rosen law firm
Securities class action services
Ocugen inc
Class period
Law firm
Class action services
Class has been
The rosen law firm pa
Rosen law firm
Nasdaq ocgn
Lass action
ROSEN, LEADING INVESTOR COUNSEL, Encourages Ocugen, Inc
NEW YORK, April 27, 2024 (GLOBE NEWSWIRE) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc..
New york
United states
Phillip kim
Laurence rosen
Rosen law firm
Securities class action services
Ocugen inc
Chinese company
Class period
Law firm
Class action services
Class has been
The rosen law firm pa
Rosen law firm
Nasdaq ocgn
Lass action
Ocugen to Present on Modifier Gene Therapy Platform at
MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,.
Nieraj jain
Tarun upadhyay
Joses pulido
Murthy chavali
Shankar musunuri
Borooah shyamanga
Benjamin bakall
Arunk upadhyay
Nalin mehta
Sahar matloob
Paul yang
University of miami
Ocugen inc
Head of research development
Seattle convention center
Nuclear hormone receptor
Ocugen Announces Dosing Completion of Subjects with
MALVERN, Pa., April 19, 2024 (GLOBE NEWSWIRE) Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering,.
United states
Syedm shah
Exchange commission
Ocugen inc
Head of communications
Retina service at gundersen health system
Huma qamar
Chief medical officer
Vice chair
Digital medicine
Retina service
Gundersen health system
Safety monitoring board
Narmada phase
Orphan receptor
Private securities litigation reform act
vimarsana © 2020. All Rights Reserved.